Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Karsten Burkert"'
Autor:
Karsten Burkert, Hadiseh Taheri, Sarkawt Hamad, Matteo Oliverio, Gabriel Peinkofer, Jan-Wilhelm Kornfeld, Wacharee Harnying, Kurt Pfannkuche, Jürgen Hescheler, Albrecht Berkessel, Tomo Šarić
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-17 (2021)
Abstract Clinical translation of pluripotent stem cell (PSC) derivatives is hindered by the tumorigenic risk from residual undifferentiated cells. Here, we identified salicylic diamines as potent agents exhibiting toxicity to murine and human PSCs bu
Externí odkaz:
https://doaj.org/article/c42a4101eb364861aadfd22f6d533faa
Autor:
Azra Fatima, Guoxing Xu, Filomain Nguemo, Alexey Kuzmenkin, Karsten Burkert, Jürgen Hescheler, Tomo Šarić
Publikováno v:
Stem Cell Research, Vol 17, Iss 2, Pp 266-272 (2016)
We report here a transgenic murine induced pluripotent stem cell (iPSC) line expressing puromycin N-acetyltransferase (PAC) and enhanced green fluorescent protein (EGFP) under the control of α-myosin heavy chain promoter. This transgenic cell line r
Externí odkaz:
https://doaj.org/article/4029f081269f4253a23342bf27f342ee
Autor:
Kurt Pfannkuche, Jürgen Hescheler, Albrecht Berkessel, Jan-Wilhelm Kornfeld, Sarkawt Hamad, Tomo Saric, Hadiseh Taheri, Wacharee Harnying, Karsten Burkert, Gabriel Peinkofer, Matteo Oliverio
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-17 (2021)
Scientific Reports
Scientific Reports
Clinical translation of pluripotent stem cell (PSC) derivatives is hindered by the tumorigenic risk from residual undifferentiated cells. Here, we identified salicylic diamines as potent agents exhibiting toxicity to murine and human PSCs but not to
Autor:
Marcel Halbach, K Urban, Gabriel Peinkofer, Benjamin Krausgrill, Jürgen Hescheler, Tomo Saric, Karsten Burkert
Publikováno v:
Stem Cells and Development. 25:1397-1406
Cardiomyocytes (CMs) derived from induced pluripotent stem cells (iPS-CMs) are promising candidates for cell therapy, drug screening, and developmental studies. It is known that iPS-CMs possess immature electrophysiological properties, but an exact c
Autor:
Guoxing Xu, Juergen Hescheler, Tomo Saric, Alexey Kuzmenkin, Karsten Burkert, Filomain Nguemo, Azra Fatima
Publikováno v:
Stem Cell Research, Vol 17, Iss 2, Pp 266-272 (2016)
We report here a transgenic murine induced pluripotent stem cell (iPSC) line expressing puromycin N-acetyltransferase (PAC) and enhanced green fluorescent protein (EGFP) under the control of α-myosin heavy chain promoter. This transgenic cell line r
Autor:
Juergen Hescheler, Catarina Brito, Tomo Saric, Karsten Burkert, Margarida Serra, Cláudia Correia, Yunjie Zheng, Manuel J.T. Carrondo, Marcos F. Q. Sousa, Paula M. Alves, Nuno Espinha
Publikováno v:
Stem Cell Reviews
Cardiomyocytes (CMs) derived from induced pluripotent stem cells (iPSCs) hold great promise for patient-specific disease modeling, drug screening and cell therapy. However, existing protocols for CM differentiation of iPSCs besides being highly depen
Autor:
Barbara Oberwallner, Ingo Morano, Yeong-Hoon Choi, Jürgen Hescheler, Christof Stamm, Tomo Saric, Karsten Burkert, Julie Albrecht, A Brodarac, Klaus Neef, Shokoufeh Mahmoodzadeh, Filomain Nguemo, Matteo Oliverio, Wolfram F. Neiss
Publikováno v:
Stem Cell Research & Therapy
Introduction Induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) may be suitable for myocardial repair. While their functional and structural properties have been extensively investigated, their response to ischemia-like conditions has not